03.07.25 -- What Should You Ask The FDA About AI

The Regional Site Manager (RSM) monitoring model eliminates numerous clinical trial risks by leveraging efficient, start-to-finish site management by a single, expert point of contact.

Here we introduce an innovative risk-monitoring solution aimed at mitigating Cytokine Release Syndrome (CRS), a critical complication in immunotherapy that often leads to prolonged hospitalization.

Gain insights from Kristina Bondareva, Head of Biostatistics at OCT Clinical, on the significance of the Addendum and the importance of adopting the estimand framework in clinical trials.

Gain an overview of FDA guidance on the use of Data Monitoring Committees (DMCs) in clinical trials and their critical role in safeguarding patient safety and ensuring unbiased decision-making.

The rise of SaaS (software-as-a-service) has transformed industries, including life sciences, by enabling new possibilities. See how it’s already helping life science organizations around the world today.

This cloud-based solution centralizes clinical and operational data to improve the efficiency and oversight of clinical trials.

Learn about a comprehensive platform used to enable the rapid delivery of clinical insights that inform both clinical and operational study decisions.

Quest Diagnostics' data licensing solutions enhance clinical trial planning by optimizing site selection, investigator identification, and regulatory compliance.